Peptide receptor radionuclide therapy (PRRT)

About this approach

PRRT attaches a radioactive substance to a molecule that binds to receptors on certain neuroendocrine tumor cells. The treatment travels through the bloodstream and delivers radiation where it binds. Lutetium-177 DOTATATE is an established example for selected somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors. Receptor imaging and clinical assessment help establish suitability. PRRT is a type of targeted radionuclide treatment, but its target and eligibility are different from PSMA-directed radioligand therapy used in selected prostate cancers.

Where it fits: Established receptor-targeted radiation for selected neuroendocrine tumors

Where this treatment is used

Approval and clinical evidence for lutetium-177 DOTATATE concern defined neuroendocrine tumor settings, not every tumor with a neuroendocrine label. The target receptors must be present, and the team also considers disease distribution, organ function, prior treatment and the broader treatment sequence. In the United States, approved use includes adults and patients aged twelve or older with the specified receptor-positive gastroenteropancreatic tumors. Treatment involves a specialist nuclear-medicine or oncology service, supporting medicines and laboratory monitoring. It can help control disease in suitable patients, but response and duration of benefit vary. Other PRRT compounds and applications may be investigational, so ask for the exact product and the evidence supporting its use in your situation.

Procedure and practical considerations

Potential risks include nausea, fatigue, reduced blood counts and kidney or liver effects. Rare long-term blood disorders and secondary cancers are important considerations with radionuclide treatment. Fertility, pregnancy and breastfeeding require specific discussion. The team may use supporting medicines to reduce treatment-related harm and will provide radiation-safety instructions for home.

Clinics reporting this approach

These clinic profiles mention this approach in their published materials. Open a profile to compare locations, services, practical details, and ways to get started.